Safety and immunogenicity of an acellular pertussis vaccine containing genetically detoxified pertussis toxin administered to pregnant women living with and without HIV and their newborns (WoMANPOWER): a randomised controlled trial in Uganda.

Saved in:
Bibliographic Details
Title: Safety and immunogenicity of an acellular pertussis vaccine containing genetically detoxified pertussis toxin administered to pregnant women living with and without HIV and their newborns (WoMANPOWER): a randomised controlled trial in Uganda.
Authors: Nakabembe E; Department of Obstetrics and Gynaecology, School of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda; Centre for Neonatal and Paediatric Infection and Vaccine Institute, City St George's, University of London, London, UK. Electronic address: drevena@yahoo.co.uk., Greenland M; Oxford Vaccine Group, NIHR Oxford Biomedical Research Centre, Department of Paediatrics, University of Oxford, Oxford, UK., Amaral K; Department of Paediatrics, University of British Columbia, Vancouver, BC, Canada; Vaccine Evaluation Center, BC Children's Hospital Research Institute, Vancouver, BC, Canada., Abu-Raya B; Departments of Paediatrics, Dalhousie University, Halifax, NS, Canada., Amone A; Makerere University-Johns Hopkins University Research Collaboration, Kampala, Uganda., Andrews N; UK Health Security Agency, Immunisation and Vaccine Preventable Diseases Department, London, UK., Cantrell L; Oxford Vaccine Group, NIHR Oxford Biomedical Research Centre, Department of Paediatrics, University of Oxford, Oxford, UK., Lesne E; UK Health Security Agency, Salisbury, UK., Gorringe A; UK Health Security Agency, Salisbury, UK., Halkerston R; UK Health Security Agency, Salisbury, UK., Mcstraw N; UK Health Security Agency, Salisbury, UK., Dixon L; UK Health Security Agency, Salisbury, UK., Hunter OF; Vaccine Evaluation Center, BC Children's Hospital Research Institute, Vancouver, BC, Canada., Heath PT; Centre for Neonatal and Paediatric Infection and Vaccine Institute, City St George's, University of London, London, UK., Imede E; Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine Uganda Research Unit, Entebbe, Uganda., Kyohere M; Centre for Neonatal and Paediatric Infection and Vaccine Institute, City St George's, University of London, London, UK; Makerere University-Johns Hopkins University Research Collaboration, Kampala, Uganda., Musoke P; Makerere University-Johns Hopkins University Research Collaboration, Kampala, Uganda., Nakimuli A; Department of Obstetrics and Gynaecology, School of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda., Sekikubo M; Department of Obstetrics and Gynaecology, School of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda., Taylor S; UK Health Security Agency, Salisbury, UK., Tusubira V; Makerere University-Johns Hopkins University Research Collaboration, Kampala, Uganda., Sadarangani M; Department of Paediatrics, University of British Columbia, Vancouver, BC, Canada; Vaccine Evaluation Center, BC Children's Hospital Research Institute, Vancouver, BC, Canada., Le Doare K; Centre for Neonatal and Paediatric Infection and Vaccine Institute, City St George's, University of London, London, UK; Makerere University-Johns Hopkins University Research Collaboration, Kampala, Uganda; UK Health Security Agency, Salisbury, UK.
Source: The Lancet. Global health [Lancet Glob Health] 2025 Jan; Vol. 13 (1), pp. e81-e97.
Publication Type: Clinical Trial, Phase II; Equivalence Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101613665 Publication Model: Print Cited Medium: Internet ISSN: 2214-109X (Electronic) Linking ISSN: 2214109X NLM ISO Abbreviation: Lancet Glob Health Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2214-109X
DOI:10.1016/S2214-109X(24)00409-1